Global Hypertension Drugs Market Key Trends, Size, Growth, Shares And Forecast Research Report 2016-2020
Hypertension, or high blood pressure (BP), develops when there is too much pressure against the inner walls of blood vessels. Depending on the pressure exerted, hypertension can be classified as:
PAH
Systemic hypertension (commonly referred to as hypertension)
PAH, high BP in the arteries that carry blood from the heart to the lungs, occurs when blood vessels narrow, making blood flow difficult. This creates pressure on the heart's right ventricle, which increases in size and becomes weaker due to the excess load, leading to heart failure. The normal pulmonary arterial pressure at rest is 14 mmHg and increases from 25 mmHg to 30 mmHg.
Systemic hypertension occurs when blood vessels that supply oxygenated blood to the body become narrower, creating pressure on the right side of the heart. Hypertension can lead to damaged organs and illnesses such as renal failure (kidney failure), aneurysm, heart failure, stroke, or heart attack. Hypertension is classified into two types:
Primary or essential hypertension: It is defined as high BP with no known cause, and includes around 90%-95% of all hypertension cases
Secondary hypertension: It is high BP with a known direct cause, including kidney disease, tumors, or birth control pills, and includes 5%-10% of all hypertension cases
Technavios analysts forecast the global hypertension drugs market to decline at a CAGR of (0.93) % during the period 2016-2020.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=711504
Covered in this report
The report covers the present scenario and the growth prospects of the global hypertension drugs market for 201652020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent hypertension and pulmonary arterial hypertension (PAH).
The market is divided into the following segments based on geography:
Americas
EMEA
APAC
New report, Global Hypertension Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Actelion Ltd.
AstraZeneca plc
Boehringer Ingelheim GmbH
Daiichi Sankyo Company, Ltd.
Novartis AG
Sanofi SA
Other prominent vendors
Actelion Pharmaceuticals
Arena Pharmaceuticals
Asahi Kasei
Bayer HealthCare
Bellerophon Therapeutics
Bial
CJ HealthCare
Conatus Pharmaceuticals
Daiichi Sankyo
Deka Pharmaceuticals
Dong-A ST
Eiger BioPharmaceuticals
Forest Laboratories
Gilead Sciences
HanAll BioPharma
Hanmi Pharmaceutical
Johnson & Johnson
LG Life Sciences
Lung Biotechnology
Lupin Pharmaceuticals
Mast Therapeutics
Merck
Northern Therapeutics
Ono Pharmaceutical
Pfizer
PhaseBio
Pluristem Therapeutics
Quantum Genomics
Radikal Therapeutics
Reata Pharmaceuticals
Serodus
sigma-tau i.f.r
SteadyMed Therapeutics
Suda
Sun Pharmaceutical Industries
Symplmed Pharmaceuticals
Takeda Pharmaceuticals
United Therapeutics
Valeant Pharmaceuticals
XOMA
Yuhan
Browse Detail Report With TOC @ http://www.researchmoz.us/global-hypertension-drugs-market-2016-2020-report.html
Market driver
Growing older population
For a full, detailed list, view our report
Market challenge
Patent expiries of major drugs
For a full, detailed list, view our report
Market trend
Increase in awareness
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Table Of Content
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
Key buying criteria
PART 05: Cardiovascular drugs market
Global pharmaceuticals market
Global cardiovascular drugs market
PART 06: Overview: Hypertension
Systemic hypertension
PAH
PART 07: Epidemiology and economic burden
Economic burden
PART 08: Pipeline portfolio
PART 09: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 10: Market segmentation by type
Global systemic hypertension drugs market
Global PAH drugs market
PART 11: Market segmentation by drug class
Systemic hypertension
PAH
PART 12: Geographical segmentation
Global hypertension drugs market by geographical segmentation 2015-2020
Hypertension drugs market in Americas
Hypertension drugs market in EMEA
Hypertension drugs market in APAC
PART 13: Market drivers
Growing older population
Rise in sedentary lifestyle
High prevalence of chronic conditions
Patient assistance programs
PART 14: Impact of drivers
PART 15: Market challenges
Patent expiries of major drugs
Adverse effects
Poor patient compliance
Availability of alternative therapies
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=711504
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Browse Our Latest Press Releases @ http://www.researchmoz.us/pressrelease